In the complex world of pharmaceutical manufacturing, the quality and availability of key intermediates directly influence the success of drug development and production. N-(4-Aminobutyl)guanidine (CAS 306-60-5) stands out as a crucial compound, serving as a fundamental building block in the synthesis of various therapeutic agents. Understanding its properties and the importance of reliable sourcing is essential for researchers and production managers alike.

N-(4-Aminobutyl)guanidine, also recognized in some contexts as Agmatine Sulfate Endogenous Agonist At, is characterized by its chemical formula C5H14N4 and a molecular weight of 130.19. Its typical form is a white powder, and its purity, often specified at a minimum of 99%, is a critical factor for its use in pharmaceutical applications. This high purity ensures that downstream synthesis reactions proceed efficiently and yield products that meet stringent regulatory standards.

As a pharmaceutical intermediate, N-(4-Aminobutyl)guanidine plays a vital role in the creation of Active Pharmaceutical Ingredients (APIs). Its unique guanidine structure allows for versatile chemical modifications, making it a valuable starting material for a range of drug candidates. The ability to reliably buy N-(4-Aminobutyl)guanidine from a trusted manufacturer is therefore paramount for maintaining consistent production cycles.

When selecting a supplier, several factors are critical for pharmaceutical applications:

  • Quality Assurance: Ensure the manufacturer adheres to Good Manufacturing Practices (GMP) and can provide comprehensive Certificates of Analysis (CoA) detailing purity, impurity profiles, and compliance with international pharmacopeia (USP, BP, EP).
  • Supply Chain Reliability: Partner with a supplier that can guarantee consistent availability and timely delivery to avoid disruptions in your production schedule.
  • Technical Data: Access to detailed technical data sheets (TDS) and safety data sheets (SDS) is crucial for safe handling and effective utilization in synthesis.
  • Scalability: Choose a manufacturer capable of scaling up production to meet evolving demand, from R&D quantities to commercial batch sizes.

For procurement specialists, identifying a cost-effective and dependable source is a primary objective. Sourcing from established chemical manufacturers in China often presents an opportunity to acquire high-quality intermediates like N-(4-Aminobutyl)guanidine at competitive prices. Engaging directly with these suppliers can facilitate better communication and potentially lead to more favorable terms for bulk purchases.

In conclusion, the effective synthesis of pharmaceuticals relies heavily on the quality and consistent supply of intermediates like N-(4-Aminobutyl)guanidine. By prioritizing reputable manufacturers and suppliers who demonstrate a commitment to quality and reliability, pharmaceutical companies can strengthen their supply chains and drive innovation.